# Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

> **NCT00070707** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 188 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal
- Asthma

## Interventions

- **DRUG:** Mometasone
- **DRUG:** Placebo
- **DRUG:** Albuterol/Salbutamol

## Key facts

- **NCT ID:** NCT00070707
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04-03
- **Primary completion:** 2003-11-26
- **Final completion:** 2003-11-26
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2024-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070707, "Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00070707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*